公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
公司地址 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
電話號碼 +1 201 847-6800
傳真號碼 --
公司網頁 http://www.bd.com
員工數量 72000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Thomas E. Polen, Jr Chairman of the Board, Chief Executive Officer and President 美元 1.40M 18/12/2025
Mr. Roland Goette Executive Vice President and President, EMEA -- 25/11/2025
Mr. Bilal Muhsin Executive Vice President and President, Connected Care Segment -- 25/11/2025
Ms. Shana Carol Neal Executive Vice President and Chief People Officer -- 25/11/2025
Mr. Antoine C. Ezell Executive Vice President, President, North America and Chief Marketing Officer -- 25/11/2025
Mr. Pavan Kumar Mocherla Executive Vice President and President, Greater Asia -- 25/11/2025
Mr. David Shan Executive Vice President and Chief Integrated Supply Chain Officer -- 25/11/2025
Ms. Michelle Quinn Executive Vice President and General Counsel -- 27/11/2024
Ms. Pamela L. Spikner Senior Vice President, Chief Accounting Officer and Controller -- 25/11/2025
Mr. Michael Feld Executive Vice President and President, Life Sciences 美元 775.00K 25/11/2025
Mr. Vitor Roque Senior Vice President of Finance, Business Units, Corporate Financial Planning, Analysis and Interim Chief Financial Officer -- 15/10/2025
 
董事會成員
董事會 職務 更新日期
Mr. Bertram L. Scott Lead Independent Director 18/12/2025
Mr. Timothy M. Ring Independent Director 18/12/2025
Mr. William M. Brown Independent Director 18/12/2025
Mr. Gregory J. Hayes Independent Director 18/12/2025
Mr. Jeffrey W. Henderson Independent Director 18/12/2025
Mr. R. Andrew Eckert Independent Director 18/12/2025
Mr. Christopher Ian Montague Jones Independent Director 18/12/2025
Mr. Thomas E. Polen, Jr Chairman of the Board, Chief Executive Officer and President 18/12/2025
Ms. Jacqueline Wright Independent Director 17/11/2025
Dr. Carrie L. Byington Independent Director 18/12/2025
Dr. Joanne Waldstreicher, M.D. Independent Director 18/12/2025
Mr. Robert L. Huffines Independent Director 17/11/2025
 
所屬ETF (更新日期: 07/11/2026 02:32)
代號 名稱 佔比% ▼ 持有日期
CFAVictoryShares US 500 Volatility Wtd ETF0.003%30/10/2026
HLALWahed FTSE USA Shariah ETF0.002%30/10/2026
LSAFLeaderSharesTM AlphaFactor® US Cr Eq ETF0.002%30/10/2026
INROiShares U.S. Industry Rotation Act ETF0.002%30/10/2026
LCFTouchstone US Large Cap Focused ETF0.002%30/10/2026
ITANSparkline Intangible Value ETF0.002%30/10/2026
MODLVictoryShares WestEnd U.S. Sector ETF0.002%30/10/2026
CUREDirexion Daily Healthcare Bull 3X ETF0.002%31/10/2026
QUSStt Strt® SPDR® MSCI USA StratFacs ETF0.002%30/10/2026
MLRGiShares MSCI USA ETF0.002%21/10/2026
SIZEiShares MSCI USA Size Factor ETF0.002%30/10/2026
CFOVictoryShares US 500 Enh Vol Wtd ETF0.002%30/10/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.002%30/10/2026
DSPYTema S&P 500 Hist Wght ETF Strat0.002%30/10/2026
CRBNiShares Low Carbon Optd MSCI ACWI ETF0.002%30/10/2026
CVLCCalvert US Large-Cp Cor Rspnb ETF0.002%30/10/2026
PSEPInnovator US Equity Power Buffer ETF-Sep0.002%30/10/2026
VUSVVanguard Wellington U.S. Val Actv ETF0.002%30/09/2026
DEUSXtrackers Russell US Multifactor ETF0.002%29/10/2026
VOTETCW Transform 500 ETF0.002%30/10/2026
  1    2    3    4    5    6    7    8   9    10    11    12    13    14    15    16    17  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.